Diffuse large B-cell lymphoma: a rare complication of an abdominal CSF pseudocyst

2017 ◽  
Vol 32 (6) ◽  
pp. 686-687
Author(s):  
Cathal Hannan ◽  
Aaron Niblock ◽  
Jeremy Hamilton ◽  
H. Neil Simms
2022 ◽  
Vol 50 (1) ◽  
pp. 030006052110677
Author(s):  
Chunhua Wang ◽  
Zanmei Lv ◽  
Yanwei Zhang

Type B lactic acidosis is a rare complication of non-tissue perfusion abnormalities caused by solid tumors or hematologic malignancies. Herein, we present the case of a 42-year-old man with type B lactic acidosis and hypoglycemia who was found to have a diffuse large B-cell lymphoma. The cause of lactic acidosis and/or hypoglycemia is thought to be the Warburg effect, which is when the metabolic rate of a rapidly growing malignant tumor is very high and dominated by glycolysis. Systemic damage from type B lactic acidosis can occur when the increased rate of glycolysis exceeds the normal muscle and liver lactic acid clearance rate. The Warburg effect is a rare but serious condition that needs to be recognized, not only in diffuse large B-cell lymphoma, but also in other malignancies. The prognosis of lactic acidosis in patients with malignant tumors is very poor. Currently, effective chemotherapy seems to be the only hope for survival.


eJHaem ◽  
2021 ◽  
Author(s):  
George Gabriel Bitar ◽  
Simon O'Connor ◽  
Ayoma D. Attygalle ◽  
Dima El‐Sharkawi ◽  
Sunil Iyengar ◽  
...  

2020 ◽  
pp. 1-4
Author(s):  
Brian R. Smith ◽  
Brian R. Smith ◽  
Ellyn Smith ◽  
Lauren N Smith

A gastro-splenic fistula is a rare complication of lymphoma, the etiology of which is poorly understood due to the narrow spectrum of cases. Additional case reports of this complication allow for increased understanding to facilitate treatment planning. This case report provides our detailed patient scenario and surgical approach to a gastro-splenic fistula in the setting of large B-cell lymphoma and compares this approach to similar cases provided in the literature review


Author(s):  
George Bitar ◽  
Ian Chau ◽  
Andrew Wotherspoon ◽  
Dima El‐Sharkawi ◽  
Sunil Iyengar ◽  
...  

2018 ◽  
Vol 1 (1-3) ◽  
pp. 1-6 ◽  
Author(s):  
Napplika Kongpolprom

Tracheal perforation is a rare and life-threatening complication following the treatment of lymphoma. There are only a few published cases of tracheal disruption from invasive lymphoma, and most of the patients did not survive. Tumor erosion and nodal necrosis from rapid tumor growth or chemotherapeutic response can cause tracheal disruption. We report here a case of tracheal perforation after chemotherapy of lymphoma. A 69-year-old Thai man presented with upper airway obstruction from a large neck mass encasing and invading the trachea. The patient was intubated to bypass the tracheal obstruction. Biopsy of the mass showed diffuse large B-cell lymphoma. Chemotherapy was urgently administered. Two days after treatment, the patient developed acute respiratory distress with high airway resistance. Emergency bronchoscopy and chest computerized tomography revealed disrupted anterior wall of trachea and endotracheal tube displacement, which created a false track into the mass. Tumor necrosis was thought to be the cause of this perforation and tube malposition. The tube was repositioned by bronchoscopic guidance. Unfortunately, the disrupted trachea could not be reconstructed. Palliative care was consequently provided, and the patient finally passed away a week after the catastrophic event. This report demonstrates clinical presentation, chest imaging, and bronchoscopic findings of tracheal perforation, which is a rare complication following the treatment of lymphoma.


Praxis ◽  
2016 ◽  
Vol 105 (1) ◽  
pp. 47-52 ◽  
Author(s):  
Andreas Lohri

Zusammenfassung. Maligne Lymphome unterteilen sich zwar in über 60 Entitäten, das grosszellige B-Zell-Lymphom, das follikuläre Lymphom, der Hodgkin und das Mantelzell-Lymphom machen aber mehr als die Hälfte aller Lymphome aus. Im revidierten Ann Arbor staging system gelten die Suffixe «A» und «B» nur noch für den Hodgkin. «E» erscheint nur noch bei Stadien I und II. Eine Knochenmarksuntersuchung wird beim Hodgkin nicht mehr verlangt, beim DLBCL (Diffuse large B cell lymphoma) nur, falls das PET keinen Knochenmark-Befall zeigt. Der PET-Untersuchung, speziell dem Interim-PET, kommt eine entscheidende Bedeutung zu. PET-gesteuerte Therapien führen zu weniger Toxizität. Gezielt wirkende Medikamente mit eindrücklicher Wirksamkeit wurden neu zugelassen. Deren Kosten sind hoch. Eine strahlen- und chemotherapiefreie Behandlung maligner Lymphome wird in Zukunft möglich sein.


Sign in / Sign up

Export Citation Format

Share Document